Diagnosed with Lung Cancer? 10 Must Read Tips to be an Empowered Patient

Education, Self-advocacy, NGS Testing, Support and the right physicians can improve your outcomes for lung cancer.

6–9 minutes
Home » Lung Cancer » Lung Cancer Overviews » Diagnosed with Lung Cancer? 10 Must Read Tips to be an Empowered Patient

Historically lung cancer was initially treated by a thoracic surgeon and most patients only saw a medical oncologist if their disease was advanced or progressed and they required systemic treatment with chemotherapy. 

This is no longer the case – ALL patients with newly diagnosed lung cancer should be evaluated by a mulitdisciplinary treatment team that includes a medical oncologist, and a surgeon in order to develop their treatment plan. This is because systemic treatment BEFORE surgery with novel precision medicines and immunotherapy can be used to more effectively treat many early-stage cancers.

Information and support are key to being an empowered patient and optimizing treatment outcomes. The following tips will help you navigate a lung cancer diagnosis and understand your treatment options to best advocate for yourself. Have tips to share or want to connect with other lung cancer patients? Join the conversation on Lung CancerConnect here.

Seek Care from a Team

Perhaps the single most important thing you can do is seek care at a cancer center where the doctors have experience treating lung cancer as part of a multidisciplinary team. These centers are staffed with all the experts that focus on lung cancer including thoracic surgeons, pulmonologists, and medical and radiation oncologists that participate in tumor boards where each patients situation is discussed among the group to ensure optimal treatment planning.

Request Early NGS-Biomarker Testing

A sample of tissue is required to confirm a diagnosis of lung cancer and test for cancer causing genomic alterations in the cancers DNA that can be targeted with precision cancer medicines or immunotherapy. All newly diagnosed patients should undergo multi-gene testing that includes PDL-1, EGFR, and ALK at the minimum as early as possible in their evaluation. These tests can be ordered separately but are best ordered as part of a comprehensive NGS panel that includes testing for other less common mutations as well. Although the comprehensive NGS panel may have more information than you initially need its best to have it done to help with long term treatment planning. A liquid biopsy (blood sample) can also be used and having both tissue and liquid tested improves the accuracy of the NGS testing more than either test alone. Moreover, information obtained on tissue can be used to assess your response to treatment most accurately.

Choosing a Surgeon

Surgery is a cornerstone of treatment for early stage NSCLC, is increasing performed after the administration of neoadjuvant systemic chemo-immunotherapy, and is complex in nature. Patients should select a surgeon that specializes in treating lung cancers. Both Thoracic and Cardiothoracic surgeons treat lung cancer however Thoracic surgeons are more likely to have greater expertise and experience in treating lung cancer. 

Ask About Neoadjuvant Therapy

Neoadjuvant therapy is systemic treatment with chemotherapy, immunotherapy or precision medicines BEFORE surgical removal of the cancer. Recent clinical trial results increasingly support treatment before surgery because it improves the ability of the surgeon to effectively remove the cancer and appears to produce better survival than just administering systemic treatment after the surgery is performed. Learn more….

Be Your Own Advocate

It’s a good idea to spend a bit of time researching your diagnosis so you can have meaningful conversations with your treatment team to engage in a shared decision-making process. Make sure you understand the type of lung cancer, its stage, and whether you have any cancer growth causing mutations. These determine your treatment options. All treatment is discussed based on the stage and the results of “next generation sequencing” (NGS). You can begin to learn about lung cancer here and keep up to date with research news and helpful tips by signing up for the Lung CancerConnect newsletter here.

Join an Online Support Community

An online support community is a great resource to help find a doctor, to share information and learn about treatment choices with other individuals in your situation. The Lung Cancer Connect online support community is safe, private, and fully moderated. Moreover, patients from leading cancer programs including Harvard – Dana Farber, Roswell Park, and Ohio State among others use the community which allows patients to interact with others from America’s top cancer centers. Join the conversation here.

Be Organized

Preparing in advance for your appointment is important.  Write down any questions you want to remember to ask, and consider bringing a close friend or family member to each appointment to take notes from your conversation with your doctor. Consider using a recorder during your appointment – this allows you to “replay” the conversation which can be very helpful. Stud­ies have shown that most patients retain only about 10% of what is told to them during an appoint­ment. It’s not unusual for patients to be treated by multiple doctors. To stay on top of the treatment routine, it’s critical to record notes from doctor appointments, questions/answers for your physician, dates of appointments, test results blood cell counts, medications and dosing schedules, prescription refills and other information.

Make Sure You Understand the Risks and Benefits of Your Treatment Options

Understand the goals of treatment so you can make the most informed treatment decisions. The goal of therapy may be cure, prolong survival, or reduce symptoms and complications of the cancer. We have created a guide to facilitate a discussion with your treating physician.

Ask about the Role of Precision Medicines & Immunotherapy

Unlike chemotherapy, which attacks normal cell as well as cancer cells, precision cancer medicines and immunotherapy are designed to target cancer cells with specific genetic alterations that allow cancer cells to grow. Lung cancers typically result from abnormal genes or gene regulation. The strategy of precision cancer medicine is to define abnormalities at the most basic genetic level. These abnormalities in the DNA are called genomic alterations and they are responsible for driving cancer cell growth. Once the cancer growth driving abnormality is identified, genomic tests are used to measure the specific genes in an individuals lung cancer that are abnormal or are not working properly. By identifying the genomic changes and knowing which genes are altered in a patient, cancer drugs that specifically attack that gene (or the later consequences of that gene) can be used to precisely target the cancer and avoid affecting healthy cells.

Ask about Clinical Trials

Ongoing research is being conducted to find new treatments for lung cancer and although immunotherapy and precision medicines have significantly improved treatment of lung cancer many patients still succumb to the disease. It is likely that the next advances will come from combining new medicines with chemo-immunotherapy. Over a dozen Antibody drug conjugates, and bispecific antibodies are currently in clinical development. By learning about clinical trials, you can identify opportunities that advance the treatment of cancer and possibly benefit your personal prognosis. Over 15 new precision cancer medicines and immunotherapy have been FDA approved based on clinical trial results in the last several years.

Overcoming Resistance: There are currently several immunotherapy clinical trials that combine an established PD-1 or PD-L1 inhibitor with another drug designed to specifically overcome resistance with an emphasis on LAG-3 and TIGIT.

There are currently more than a dozen different LAG-3 inhibiting agents in development and just as many phase 3 studies that exploring anti-TIGIT therapy in combination with checkpoint inhibitors. Learn more about clinical trials

Consider a Second Opinion

The more you can learn about your diagnosis and your treatment options, the better chance of receiving the best treatment. Getting a second opinion will help you understand ALL available treatment options and provide reassurance to you and your family that you are receiving the most appropriate therapy. A second opinion should be obtained at a major cancer treatment program that treats lots of lung cancer patients and where physicians work in a “team” format to determine treatment.

Learn more about why getting a second opinion may be the most important decision you make.

Make Sure You Have an Overall Care Coordinator

Everyone needs a single point of contact who is responsible for your overall care. This is typically your gynecologic oncologist. Without a “quarterback” the potential for miscommunication, and frustration is considerable. Make sure you have one primary care coordinator that you can contact for follow-up questions and concerns during the course of your treatment.

Keep Current with Advances in Lung Cancer Treatment Here.

You May Be Interested In